Literature DB >> 7446418

Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.

C V Leier, C E Desch, R D Magorien, D W Triffon, D V Unverferth, H Boudoulas, R P Lewis.   

Abstract

Hydralazine possesses positive inotropic properties in animal model preparations. To determine whether this vasodilator elicits a positive inotropic response in the failing human ventricle, hydralazine, 75 or 100 mg, was administered orally to 14 patients with left ventricular dysfunction and congestive heart failure; the results were compared with those of first-dose prazosin at 5 and 10 mg. The duration of the preejection period and the isovolumic developed pressure/duration of isovolumic contraction (delta P/delta t) were used as indexes of inotropy. Prazosin did not effect a significant response in the duration of the preejection period or in the delta P/delta t. Hydralazine significantly shortened the preejection period and increased the delta P/delta t over 8 hours after administration; these data suggest that hydralazine elicits a positive inotropic response in the failing human ventricle.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7446418     DOI: 10.1016/0002-9149(80)90364-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.

Authors:  A P Good; D V Unverferth; C V Leier
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

Review 2.  Systolic time intervals: a review of the method in the non-invasive investigation of cardiac function in health, disease and clinical pharmacology.

Authors:  S Hassan; P Turner
Journal:  Postgrad Med J       Date:  1983-07       Impact factor: 2.401

3.  Usefulness of the systolic time intervals in cardiovascular clinical cardiology.

Authors:  R P Lewis; H Boudoulas; C V Leier; D V Unverferth; A M Weissler
Journal:  Trans Am Clin Climatol Assoc       Date:  1982

4.  Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.

Authors:  P Daly; J L Rouleau; D Cousineau; J H Burgess; K Chatterjee
Journal:  Br Heart J       Date:  1986-08

5.  Cellular mechanism of the positive inotropic effect of hydralazine in mammalian myocardium.

Authors:  D G Hurrell; C L Perreault; L Miao; B J Ransil; J P Morgan
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

Review 6.  Vasodilator therapy in chronic congestive heart failure.

Authors:  A B Schwartz; K Chatterjee
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

Review 7.  Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

Authors:  W F Stanaszek; D Kellerman; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

Review 8.  Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.

Authors:  J P Mulrow; M H Crawford
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.